DIabetes REsearCh on Patient sTratification (DIRECT): GLP-1R Agonists
Status:
Completed
Trial end date:
2015-12-11
Target enrollment:
Participant gender:
Summary
The purpose of this study is to collect a cohort of patients treated with GLP-1R Agonists and
to assess phenotypic, genetic and genomic biomarkers of glycaemic response to these agents.
Phase:
N/A
Details
Lead Sponsor:
Evan Pearson University of Dundee
Collaborators:
Newcastle-upon-Tyne Hospitals NHS Trust Oxford University Hospitals NHS Trust Royal Devon and Exeter NHS Foundation Trust